| Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma A Jusakul, I Cutcutache, CH Yong, JQ Lim, MN Huang, N Padmanabhan, ... Cancer discovery 7 (10), 1116-1135, 2017 | 719 | 2017 |
| PTHrP expression in human MDA-MB-231 breast cancer cells is critical for tumor growth and survival and osteoblast inhibition L Zheng, K Zhu, H Jiao, Z Zhao, L Zhang, M Liu, W Deng, D Chen, Z Yao, ... International journal of biological sciences 9 (8), 830, 2013 | 34 | 2013 |
| Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma. Cancer Discov. 2017; 7 (10): 1116–35 A Jusakul, I Cutcutache, CH Yong, JQ Lim, MN Huang, N Padmanabhan, ... doi. org/10.1158/2159-8290. CD-17-0368, 0 | 24 | |
| Recurrent mutations in topoisomerase IIα cause a previously undescribed mutator phenotype in human cancers A Boot, M Liu, N Stantial, V Shah, W Yu, KC Nitiss, JL Nitiss, ... Proceedings of the National Academy of Sciences 119 (4), e2114024119, 2022 | 23 | 2022 |
| STING-dependent cytosolic DNA sensor pathways regulate NKG2D ligand expression N Le Bert, AR Lam, SSW Ho, YJ Shen, MM Liu, S Gasser Oncoimmunology 3 (6), e29259, 2014 | 22 | 2014 |
| Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease G Assante, S Chandrasekaran, S Ng, A Tourna, CH Chung, KA Isse, ... Genome medicine 14 (1), 67, 2022 | 12 | 2022 |
| mSigHdp: hierarchical Dirichlet process mixture modeling for mutational signature discovery M Liu, Y Wu, N Jiang, A Boot, SG Rozen NAR Genomics and Bioinformatics 5 (1), lqad005, 2023 | 6 | 2023 |
| Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma. Cancer Discov. 7, 1116–1135. doi: 10.1158/2159-8290 A Jusakul, I Cutcutache, CH Yong, JQ Lim, MN Huang, N Padmanabhan CD-17-0368, 2017 | 4 | 2017 |
| Mutational processes in cancer preferentially affect binding of particular transcription factors M Liu, A Boot, AWT Ng, R Gordân, SG Rozen Scientific reports 11 (1), 3339, 2021 | 3 | 2021 |
| Deep whole-genome analysis of 494 hepatocellular carcinomas L Chen, C Zhang, R Xue, M Liu, J Bai, J Bao, Y Wang, N Jiang, Z Li, ... Nature, 1-8, 2024 | 2 | 2024 |
| Computational Approaches to Studying the Causes and Consequences of Mutational Signatures L Mo PQDT-Global, 2021 | 1 | 2021 |
| Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease (vol 14, 67, 2022) G Assante, S Chandrasekaran, S Ng, A Tourna, CH Chung, KA Isse, ... GENOME MEDICINE 15 (1), 2023 | | 2023 |
| Association of liver metastases, tumor microenvironment, and treatment outcomes in patients with urothelial bladder cancer treated with tislelizumab. L Xu, M Liu, R Huang, X Ma, X Wu, V Ramakrishnan, L Zhang, Y Zhang Journal of Clinical Oncology 41 (6_suppl), 537-537, 2023 | | 2023 |
| Correction: Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease G Assante, S Chandrasekaran, S Ng, A Tourna, CH Chung, KA Isse, ... Genome Medicine 15, 2023 | | 2023 |
| DEAR: Dual-Level Self-attention GRU for Online Early Prediction of Sepsis Y Zhao, Y Wu, M Liu, X Cai, Y Zhang, X Yuan International Conference on Web Information Systems and Applications, 424-435, 2022 | | 2022 |
| Acetyl coenzyme A metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease G Assante, S Chandrasekaran, S Ng, A Tourna, C Chung, K Isse, J Banks, ... JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 37, 24-25, 2022 | | 2022 |
Steven G. RozenDuke University School of MedicineVerified email at duke.edu
